Study for people at high risk of getting HIV
Part of Immune system & allergy, Infections clinical trials.
This registry study looks at people who are HIV-negative but at high risk of getting HIV, to better understand risk and care needs. If you qualify, you may be asked to share health and behavior information to help guide future prevention efforts.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be older than 18 (and under 100)
- You must currently be HIV-negative
- You must be considered at high risk for getting HIV
- You have to have been engaging in HIV-risk situations (for example: not using condoms often, recent STI, recent PEP, or frequent chemsex)
- You must sign a written consent form to join
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an observational study that follows people to better understand how HIV and other infections (like sexually transmitted infections) happen and change over time. It may help researchers improve prevention and care, but it is mainly for monitoring rather than testing a new treatment.
This study tests a personalized care coordination program to help Black men who have sex with men stay on HIV prevention. It focuses on men who are new to or have stopped PrEP and want to reduce their HIV risk.
This study tests an investigational long-acting shot (MK-8527) to prevent HIV. It is for HIV-negative people who are at higher risk through anal sex without condoms, and who have not used other long-acting HIV prevention before.
This study looks at ways to prevent HIV in Latino adults who are at higher risk. It may help by testing HIV prevention approaches in specific local communities.
This study tests whether giving at-home HIV and syphilis self-test kits to men who have sex with men (MSM) can help more people learn their status and get linked to care. It also looks at how sharing test results with partners might increase testing and prevent the spread of infections.
This study is for cis-gender men who are HIV-negative and at risk for HIV. It tests a program to help you start and stay on PrEP (medication to prevent HIV).
Hear when a new HIV Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.